https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-imjudo
Drug Trials Snapshots: IMJUDO | FDA
IMJUDO is a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking antibody indicated in combination with durvalumab, for the treatment of adult...
drug trials snapshotsimjudofda
https://www.medicines.org.uk/emc/product/14841/smpc
IMJUDO 20 mg/ml concentrate for solution for infusion - Summary of Product Characteristics (SmPC) -...
IMJUDO 20 mg/ml concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by AstraZeneca UK Limited